{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:47Z","timestamp":1790660987297,"version":"4.1.0"},"reference-count":52,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIH\/NHLBI","award":["K24 HL152440"],"award-info":[{"award-number":["K24 HL152440"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT173471"],"award-info":[{"award-number":["PJT173471"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["program grant IDs 358395 and 571281"],"award-info":[{"award-number":["program grant IDs 358395 and 571281"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["project grant ID 211086"],"award-info":[{"award-number":["project grant ID 211086"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Nova Scotia New Health Investigator grant"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2025,4,20]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>This study sought to determine whether the association between attaining specific glycated hemoglobin (HbA<jats:sub>1c<\/jats:sub>) targets (&lt;7.0% (&lt;53 mmol\/mol) and \u22658.0% (\u226564\u2009mmol\/mol) compared with 7.0%\u20137.9%) over time and risk of incident coronary artery disease (CAD) was dependent on haptoglobin (Hp) phenotype in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>Prospectively collected HbA<jats:sub>1c<\/jats:sub> data from the ADVANCE biomarker case-cohort study, updated at 6 months and every 12 months thereafter over a median of 5.0 (IQR 4.5\u20135.3) years, were analyzed in relation to incident CAD in the Hp2-2 (n=1323) and non-Hp2-2 (n=2069) phenotypes separately using weighted multivariable-adjusted Cox regression models. Additional a priori stratifications by sex, race, previous cardiovascular disease (CVD), and type 2 diabetes duration were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Mean HbA<jats:sub>1c<\/jats:sub> was similar in each phenotype group throughout the study. Compared with HbA<jats:sub>1c<\/jats:sub> of 7.0%\u20137.9%, HbA<jats:sub>1c<\/jats:sub> &lt;7.0% was not associated with CAD risk for any phenotype group or subgroup. HbA<jats:sub>1c<\/jats:sub> \u22658.0% compared with 7.0%\u20137.9% over time was associated with higher CAD risk for the Hp2-2 phenotype only (HR 1.53, 95% CI 1.01 to 2.32; no significant association in the non-Hp2-2 type: 1.26, 0.89 to 1.77, p-interaction=0.71); this was pronounced when those with previous CVD at baseline were excluded (Hp2-2: 2.80, 1.41 to 5.53, p-interaction=0.03). Compared with HbA<jats:sub>1c<\/jats:sub> of &lt;8.0%, having HbA<jats:sub>1c<\/jats:sub> \u22658.0% was associated with a 59% higher CAD risk among participants with the Hp2-2 phenotype (1.59, 1.12 to 2.26) and a 39% higher CAD risk among participants without the Hp2-2 phenotype (1.39, 1.03 to 1.88, p-interaction=0.97).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The present ADVANCE analysis suggests that not having HbA<jats:sub>1c<\/jats:sub> \u22658.0%, rather than achieving HbA<jats:sub>1c<\/jats:sub> &lt;7.0%, was found to be particularly important for CAD prevention among people with type 2 diabetes and the common Hp2-2 phenotype. While the subgroup analyses were likely underpowered, their inclusion is hypothesis generating and can be used in future meta-analyses to improve power and generalizability.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2024-004713","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:50:12Z","timestamp":1746571812000},"page":"e004713","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between time-varying achieved HbA<sub>1c<\/sub> and risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct00145925","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3584-2227","authenticated-orcid":false,"given":"Leah E","family":"Cahill","sequence":"first","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Nova Scotia Health, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Nova Scotia Health, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0412-3290","authenticated-orcid":false,"given":"Samantha K","family":"Lavall\u00e9e","sequence":"additional","affiliation":[{"name":"Nova Scotia Health, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P","family":"Levy","sequence":"additional","affiliation":[{"name":"Technion Israel Institute of Technology, Haifa, Nova Scotia, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allie S","family":"Carew","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Nova Scotia Health, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sapp","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Nova Scotia Health, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Samuel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Departments of Cardiology and Epidemiology, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-7151","authenticated-orcid":false,"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins, Baltimore, Maryland, USA"},{"name":"Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[{"name":"NHLI, Faculty of Medicine, International Centre for Circulatory Health, Paddington, UK"},{"name":"George Institute for Global Health, School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[{"name":"Clinique Ambroise Par\u00e9, Neuilly-sur-Seine, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harrap","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[{"name":"University of Milano-Bicocca, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-2869","authenticated-orcid":false,"given":"Katie","family":"Harris","sequence":"additional","affiliation":[{"name":"George Brown Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[{"name":"George Brown Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[{"name":"George Institute for Global Health, School of Public Health, Imperial College London, London, UK"},{"name":"George Brown Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rimm","sequence":"additional","affiliation":[{"name":"Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"},{"name":"Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2025073112011924000_13.3.e004713.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"2025073112011924000_13.3.e004713.2","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcjd.2017.10.030","article-title":"Targets for Glycemic Control","volume":"42 Suppl 1","author":"Imran","year":"2018","journal-title":"Can J Diabetes"},{"key":"2025073112011924000_13.3.e004713.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"2025073112011924000_13.3.e004713.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"2025073112011924000_13.3.e004713.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000251741.65179.56"},{"key":"2025073112011924000_13.3.e004713.6","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0450"},{"key":"2025073112011924000_13.3.e004713.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2007.00898.x"},{"key":"2025073112011924000_13.3.e004713.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.063"},{"key":"2025073112011924000_13.3.e004713.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.076"},{"key":"2025073112011924000_13.3.e004713.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000076889.23082.F1"},{"key":"2025073112011924000_13.3.e004713.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000156653.05853.b9"},{"key":"2025073112011924000_13.3.e004713.12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/ATVBAHA.118.312232","article-title":"Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery Disease","volume":"39","author":"Asleh","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025073112011924000_13.3.e004713.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.04.079"},{"key":"2025073112011924000_13.3.e004713.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.051"},{"key":"2025073112011924000_13.3.e004713.15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/dc23-2165","article-title":"Haptoglobin Phenotype and Intensive Glycemic Control for Coronary Artery Disease Risk Reduction in People With Type 2 Diabetes: The ADVANCE Study","volume":"47","author":"Cahill","year":"2024","journal-title":"Diabetes Care"},{"key":"2025073112011924000_13.3.e004713.16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/dc23-0760","article-title":"The Relationship Between Time-Varying Achieved HbA1c and Risk of Coronary Events Depends on Haptoglobin Phenotype Among White and Black ACCORD Participants","volume":"46","author":"Cahill","year":"2023","journal-title":"Diabetes Care"},{"key":"2025073112011924000_13.3.e004713.17","doi-asserted-by":"publisher","DOI":"10.1007\/s001250100612"},{"key":"2025073112011924000_13.3.e004713.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1165"},{"key":"2025073112011924000_13.3.e004713.19","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2625"},{"key":"2025073112011924000_13.3.e004713.20","doi-asserted-by":"crossref","unstructured":"Woodward M . Epidemiology: study design and data analysis. 3rd edition. New York: Chapman and Hall\/CRC, 2013.","DOI":"10.1201\/b16343"},{"key":"2025073112011924000_13.3.e004713.21","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1111\/dom.15935","article-title":"Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study","volume":"26","author":"Pikkemaat","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025073112011924000_13.3.e004713.22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1515\/cclm-2013-0018","article-title":"An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype","volume":"51","author":"Levy","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"2025073112011924000_13.3.e004713.23","doi-asserted-by":"publisher","DOI":"10.2174\/156720208785425675"},{"key":"2025073112011924000_13.3.e004713.24","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(84)90342-5"},{"key":"2025073112011924000_13.3.e004713.25","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S013"},{"key":"2025073112011924000_13.3.e004713.26","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.1"},{"key":"2025073112011924000_13.3.e004713.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100681","article-title":"Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial","volume":"18","author":"Cahill","year":"2024","journal-title":"Am J Prev Cardiol"},{"key":"2025073112011924000_13.3.e004713.28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12933-024-02448-z","article-title":"The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study","volume":"23","author":"Carew","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2025073112011924000_13.3.e004713.29","doi-asserted-by":"crossref","unstructured":"Xue X , Xie X , Gunter M , et al . Testing the proportional hazards assumption in case-cohort analysis. BMC Med Res Methodol 2013;13. doi:10.1186\/1471-2288-13-88","DOI":"10.1186\/1471-2288-13-88"},{"key":"2025073112011924000_13.3.e004713.30","unstructured":"National Insitutes of Health . NIH policy on sex as a biological variable. Natl. Institues Heath Off. Res. Womens Health. n.d. Available: https:\/\/orwh.od.nih.gov\/sex-gender\/nih-policy-sex-biological-variable"},{"key":"2025073112011924000_13.3.e004713.31","doi-asserted-by":"publisher","DOI":"10.2337\/DC23-S006"},{"key":"2025073112011924000_13.3.e004713.32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.4.720"},{"key":"2025073112011924000_13.3.e004713.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13304"},{"key":"2025073112011924000_13.3.e004713.34","unstructured":"Harrell F . Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, USA: Springer-Verlag New York, Inc, 2010."},{"key":"2025073112011924000_13.3.e004713.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.149435"},{"key":"2025073112011924000_13.3.e004713.36","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3693"},{"key":"2025073112011924000_13.3.e004713.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.04.032"},{"key":"2025073112011924000_13.3.e004713.38","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.10.1589"},{"key":"2025073112011924000_13.3.e004713.39","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13164839","article-title":"Diabetes Management Based on the Phenotype and Stage of the Disease: An Expert Proposal from the AGORA Diabetes Collaborative Group","volume":"13","author":"G\u00f3mez-Peralta","year":"2024","journal-title":"J Clin Med"},{"key":"2025073112011924000_13.3.e004713.40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2025073112011924000_13.3.e004713.41","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2337\/dc23-2274","article-title":"Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes","volume":"47","author":"Kwak","year":"2024","journal-title":"Diabetes Care"},{"key":"2025073112011924000_13.3.e004713.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2012.00716.x"},{"key":"2025073112011924000_13.3.e004713.43","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3510"},{"key":"2025073112011924000_13.3.e004713.44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41598-022-20496-x","article-title":"Genotype-specific reference interval of haptoglobin tests in a Chinese population on the BN II System","volume":"13","author":"Lei","year":"2023","journal-title":"Sci Rep"},{"key":"2025073112011924000_13.3.e004713.45","doi-asserted-by":"publisher","DOI":"10.1177\/1479164116645247"},{"key":"2025073112011924000_13.3.e004713.46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12933-018-0662-7","article-title":"Mendelian randomization analysis to assess a causal effect of haptoglobin on macroangiopathy in Chinese type 2 diabetes patients","volume":"17","author":"Wang","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2025073112011924000_13.3.e004713.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2007.04.018"},{"key":"2025073112011924000_13.3.e004713.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.09.015"},{"key":"2025073112011924000_13.3.e004713.49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijcard.2016.11.220","article-title":"Higher post-acute myocardial infarction plasma haptoglobin level is associated with poor long-term overall survival","volume":"229","author":"Chiang","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025073112011924000_13.3.e004713.50","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0366"},{"key":"2025073112011924000_13.3.e004713.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2003.08.009"},{"key":"2025073112011924000_13.3.e004713.52","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2024-004713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:01:36Z","timestamp":1753988496000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2024-004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5,6]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjdrc-2024-004713"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2024-004713","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}